Company / PP&E (Net)
CASTLE BIOSCIENCES INC PP&E (Net) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$97.4M
FY2025
5-year range
$9.5M / $97.4M
FY2021-FY2025
Trend
+90.6%
vs FY2024
Sector context
#88 of 138
Health Care
What the data says
At $97M, CASTLE BIOSCIENCES INC's pp&e (net) ranks #88 of 138 in the Health Care sector. PP&E (Net) has increased for 6 consecutive years, from $2M in FY2018 to $97M in FY2025.
Based on SEC 10-K filings.
$97M in FY2025 with a 5-year CAGR of +68.8%.
Improved from $14M to $97M over the past 3 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +89.5%
- 5-Year CAGR
- +68.8%
- 10-Year CAGR
- -
Sector benchmark
#88 of 138 in Health CareTop 64% of 138This company $97.4M Sector average $1.4B
▼
-93.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +68.8%, indicating consistent growth.
- In FY2025, pp&e (net) increased 90.6% year-over-year.
- Ranks #88 out of 138 companies in the Health Care sector.
- Lowest pp&e (net) in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $97.4M | +90.6% |
| FY2024 | $51.1M | - |
| FY2023 | - | - |
| FY2022 | $14.3M | +50.7% |
| FY2021 | $9.5M | +33.8% |
| FY2020 | $7.1M | +244.8% |
| FY2019 | $2.1M | +34.7% |
| FY2018 | $1.5M | - |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026